Company News

  • Snibe become the 1st in China who received FDA Cleared on CLIA product

    14th July 2017- Snibe Co., Ltd. receives the FDA clearance on the commercialization of TSH on MaglumiTM 2000 fully-automatic chemiluminescence immunoassay system. (US FDA 510 (k), K NO. : K162698) .It is the 1st company in China who received FDA cleared on CLIA product.
    Issue date:2017-10-27
  • Snibe Showcases Total Lab Automation at MEDLAB 2020

    From Feb. 3rd to 6th, Snibe brings the latest product SATLAS-TCA to Medlab Middle East with booth NO.: Z5.C20. in Dubai, United Arab Emirates, one of the largest and most influential medical exhibitions across the world, attracting more than 25,800 professional visitors, providing a great platform for all to share and communicate the recent technology available in the IVD, and medical laboratory market.
    Issue date:2020-02-06
  • Snibe Shines at Medica 2019

    Medica, known as the world's largest trade fair for medical technology, was held in Dusseldorf, Germany, from November 18th to 21st.
    Issue date:2019-11-21

New Product

More >>

About Us

To Be Global IVD Pioneer

Focus On Chemiluminescence Immunoassay For 25years

145Countries

12000Units

More